Zoetis | ZTS - Cash And Equivalent



Zoetis reported $1.44B in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
AbbVie USD 5.18B 349M Mar/2025
Align Technology USD 873.01M 170.88M Mar/2025
Bayer EUR 4.56B 542M Jun/2025
Bristol-Myers Squibb USD 12.6B 1.72B Jun/2025
Charles River Laboratories USD 182.82M 46.53M Jun/2025
Dentsply International USD 359M 39M Jun/2025
Eli Lilly USD 3.38B 282.6M Jun/2025
Henry Schein USD 145M 18M Jun/2025
Idexx Laboratories USD 164.59M 624K Jun/2025
Illumina USD 934M 179M Jun/2025
IQVIA Holdings USD 2.04B 299M Jun/2025
J&J USD 38.47B 32.35B Mar/2025
Laboratory Of America USD 647.3M 277.9M Jun/2025
Merck USD 8.01B 622M Jun/2025
Neogen USD 129M 1.3M May/2025
Pacira USD 300.48M 16.87M Jun/2025
Perrigo USD 454.2M 44.3M Jun/2025
Pfizer USD 1.64B 208M Jun/2025
Quest Diagnostics USD 319M 131M Jun/2025
Sanofi 15.36B 7.37B Jun/2025
Sanofi 15.36B 7.92B Jun/2025
Zoetis USD 1.44B 286M Jun/2025